Chronix presents head/neck cancer data at ASCO

Related Posts

27 Sep

Zylö Therapeutics Closes $4 Million Series A Financing

Zylö Therapeutics Inc., dedicated to developing a transformational topical delivery platform, announced that on September 21, 2019, it effected…

read more
09 Feb

WiLS Partners with Scrible to Help Wisconsin Schools Affordably Access its Research and Writing Super App

Scrible, the super app that streamlines the research and writing process for students and educators, announced today its partnership…

read more
19 Aug

State of the art e-glasses giving sight and changing the lives of the legally blind

A new invention is helping to give visually-impaired Kiwis a new perspective on life.
For almost his whole life, 22-year-old Emil Secker…

read more
16 May

Carbonite Charitable Fund Awards Grants to Six STEM Organizations

Today, Carbonite, Inc., a global leader in data protection, announced that the Carbonite Charitable Fund awarded grants to six…

read more
21 Aug

Pet Startups in Korea Providing Innovative Solutions – Best of 2020

Pet startups in Korea are on the rise because it is estimated that South Koreans spend $2.5 billion a…

read more
18 Jan

Pixability Taps Duffy As CMO, Ahuja To Lead Engineering

The video advertising software firm Pixability has hired two new executives to its senior ranks, seeking to further…

read more
28 Jun

VIA Folio Processes Closing for Myomo, the First Exchange-Traded Reg A+ IPO

VIA Folio is pleased to announce that it has processed the closing of Myomo’s Reg A+ IPO, the first…

read more
05 Oct

Siamab Therapeutics and Boehringer Ingelheim Announce Strategic Cancer Immunology Discovery Collaboration to Develop Antibody Therapeutics Targeting Multiple Solid Tumors

Siamab Therapeutics, Inc. and Boehringer Ingelheim announced today that they have entered into a strategic discovery collaboration with the…

read more
29 Jul

Siamab Therapeutics Announces Publication in PLOS ONE of Positive Data from Preclinical Studies of its ST1 Antibody Therapeutic in Development for Ovarian Cancer

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, today announced the publication of positive preclinical data…

read more
28 Mar

UltraCell completes $5 million round of fundraising with plans for a Buffalo factory

UltraCell Insulation, a runner-up in the 43North business plan competition in 2016, has wrapped up a $5 million funding…

read more